← Leaderboards
Andrew Michael Lamade
University Of Pittsburgh At Pittsburgh
$203,806
Attributed
$203,806
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51K · FY2018–22$100K$75K$50K$25K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$203,806 · 1
By mechanism
F30$203,806 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Robert S. Clark$12,893,742
- Jun Chen$22,616,112
- Hulya Bayir$16,376,338
- Henry E Wang$15,583,055
- Mioara D. Manole$2,585,254
Others in their field
Other Emerging Leaders on “Clinical Data”
- Leonard Freedman · Leidos Biomedical Research, Inc.$833,755,972
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lynn Briscoe · Leidos Biomedical Research, Inc.$276,664,471
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$173,245,711
Research focus
Clinical DataAnimalsAnimal ModelAcuteApoptosis Inducing FactorBaseBioenergeticsBlood - Brain Barrier AnatomyBlood FlowBrainBrain IschemiaBrain RegionC57bl/6 MouseCareerCause Of DeathCell Culture TechniquesCell DeathCell DivisionCell ModelCell NucleusCellsCessation Of LifeCirculating BiomarkersClinically Relevant
Grant awards (5)
Targeting mitochondrial PARP1 in neuronal ischemia-reperfusion injury$2,710
F30 · FY2022 · HL · contact PI
Targeting mitochondrial PARP1 in neuronal ischemia-reperfusion injury$51,036
F30 · FY2021 · HL · contact PI
Targeting mitochondrial PARP1 in neuronal ischemia-reperfusion injury$50,520
F30 · FY2020 · HL · contact PI
Targeting mitochondrial PARP1 in neuronal ischemia-reperfusion injury$50,016
F30 · FY2019 · HL · contact PI
Targeting mitochondrial PARP1 in neuronal ischemia-reperfusion injury$49,524
F30 · FY2018 · HL · contact PI